AI Companion for Doctors in 2026: Tools and How to Choose One

An ai companion for doctors is software that works beside a clinician to draft visit notes, answer clinical questions with cited sources, and handle routine paperwork. The physician still makes every decision. In 2026 the field splits into two main jobs: ambient scribes and clinical decision support. This guide maps the products in each, gives you a pre-adoption checklist, and explains when to buy and when to build.

What is an AI Companion for Doctors?

An AI companion for doctors works alongside a clinician during and between visits. It handles documentation, evidence lookup, and routine tasks, and the doctor keeps every decision. This article uses three terms:

• Ambient scribe. It listens to the visit and drafts a structured note for the clinician to review and sign, covering history, assessment, and plan. Some scribes also propose codes or stage orders for confirmation.
• Clinical decision support (CDS). It answers questions about dosing, differentials, interactions, and guideline thresholds, and it cites the sources behind each answer. Its value depends on how good and how recent those sources are.
• Assistant tasks. This is the work around the visit: referral letters, prior authorization drafts, patient-friendly summaries, and inbox replies. Many scribes and CDS tools now bundle these tasks.

Investment went to scribes first. Menlo Ventures called ambient scribes “healthcare AI’s first breakout category,” and investors put at least $1 billion into the space in 2025 alone. Documentation time is measurable before and after a pilot, so it is easy to test and easy to justify to a CFO. Decision support followed, and the two jobs are now merging into single products.

One rule holds across all three jobs. The companion drafts and suggests, and the clinician reviews, edits, and signs. A tool that removes that step is a different kind of product with different regulatory exposure.

Which AI Companion for Doctors Tools are Clinicians Using in 2026?

The names you will hear most are Suki, OpenEvidence, ChatGPT for Clinicians, and Heidi, plus scribes built into EHRs. The list below describes the market rather than ranking it. The right fit depends on your specialty, your EHR, and your governance model.

Suki started as a scribe. Its new Ask feature runs on Wolters Kluwer’s UpToDate Expert AI inside the Suki for Clinicians app, so a clinician can check evidence without leaving the documentation workflow.

OpenEvidence says more American physicians use it than all other AI platforms combined. That is the company’s own claim and has not been independently measured.

ChatGPT for Clinicians is separate from ChatGPT for Healthcare, OpenAI’s enterprise product. In September, ChatGPT for Healthcare gained a read-only Epic connection and a nine-source Healthcare Public Data plugin. Eligible clinician accounts received the plugin but not the Epic access. If you need chart context, that difference matters.

How does an Ambient Scribe Differ from a Clinical Decision Support Tool?

An ambient scribe records the visit and drafts documentation. A clinical decision support tool answers clinical questions and points to evidence. One writes down what already happened. The other influences what happens next, so the two carry different risks.

Scribe risks sit in the note. A draft can leave out a symptom the patient mentioned or add a detail nobody said, such as a medication, a laterality, or an exam finding. Both errors look plausible in a polished note. Recording also raises a consent question, and the answer depends on state law and your organization’s policy.

Decision support risks sit in the answer, which may rest on an outdated guideline or on no visible source at all. The tool may also move from supporting your judgment to directing it, and that brings in regulation. The FDA guidance on clinical decision support software separates software that is not a device, which gives a professional information they can independently review, from software that is. A tool is more likely to be treated as a device if it analyzes images or physiological signals, or if it issues a specific directive without showing its basis. Put simply: if you can see the evidence and decide for yourself, the tool supports you. If it decides and you mainly accept, expect device-level scrutiny.

The line between product types is fading. Suki adding Ask puts scribe and CDS in one app. Heidi’s push toward prescribing and test ordering goes further, because it would put the product under device-level FDA review, which is why the company is pursuing approval. When a vendor adds a feature, check which side of the FDA line it falls on.

What should a Practice Check Before Adopting an AI Companion?

Check four things: privacy terms, how deeply the tool integrates with your EHR, whether it shows its sources, and how clinicians will review its output. Work through this checklist before signing:

1. A signed business associate agreement. If the tool touches protected health information for a covered entity, you need a BAA. A consumer health app is not the same as a clinician product sold under BAA terms, even when the two share a brand. Read the HHS HIPAA Privacy Rule and confirm which product tier your clinicians will actually log into.
2. EHR connection depth. Ask whether the integration is read-only or can write back. Read-only access leaves copy-paste work for your staff. Write-back saves clicks but needs tighter controls on what gets filed and who signs it.
3. Source transparency. Decision support answers should cite named sources, such as UpToDate, specific guidelines, or journal articles a clinician can open. An answer with no citation is a liability.
4. Data retention and training use. Find out how long the vendor keeps audio, transcripts, and notes, whether any of that data trains models, and whether you can opt out. Get the answers in the contract, not in a sales deck.
5. A supervised pilot. Start with a small group of clinicians who sign off on every AI-drafted note before it enters the chart, and track their edits. Recurring corrections, such as wrong medication names or missed negatives, tell you more than any vendor accuracy figure.

Name an owner for each item. Gaps usually appear between IT, compliance, and clinical leadership, because each group assumes another one checked.

When should a Hospital Build a Custom AI companion instead of Buying One?

Build when off-the-shelf tools cannot reach your hospital’s own data, workflows, languages, or approval steps. Buy when you need standard note drafting or evidence lookup, which commercial scribes and CDS tools already do well and at scale.

Common gaps that push a hospital toward a custom build:

• Specialty templates. Oncology, psychiatry, and procedural specialties often need note structures generic scribes do not produce well.
• Regional languages. Visits in languages a commercial model handles poorly, or visits that switch between languages, can produce weak drafts.
• Internal protocols. Answers may need to follow your formulary, pathways, and escalation rules, not just published guidelines.
• Downstream systems. You may need connections to scheduling, billing, pharmacy, or lab systems no vendor integrates with.

Building does not mean replacing what you bought. A custom layer can sit beside a commercial scribe, take its draft note, apply your templates, check it against internal protocols, route it through your approval steps, and push results to systems the vendor never touches. You keep the vendor’s core model and add the parts specific to your hospital.

If your team lacks in-house AI engineers, you can bring in an outside developer. sourcecodelab.ai offers custom AI development for healthcare workflows, and its KD Hospital case study shows how it approached a hospital engagement. Whichever partner you consider, apply the checklist above to the custom build. A tool you built yourself still needs a BAA path, write-back controls, cited sources, and clinician sign-off.